Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN2B Antikörper (AA 61-71)

CDKN2B Reaktivität: Human, Affe WB, ELISA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN1834022
  • Target Alle CDKN2B Antikörper anzeigen
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Bindungsspezifität
    • 13
    • 12
    • 9
    • 8
    • 7
    • 6
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 61-71
    Reaktivität
    • 66
    • 16
    • 15
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Affe
    Wirt
    • 57
    • 9
    • 1
    Ziege
    Klonalität
    • 59
    • 8
    Polyklonal
    Konjugat
    • 31
    • 7
    • 7
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CDKN2B Antikörper ist unkonjugiert
    Applikation
    • 55
    • 43
    • 37
    • 35
    • 25
    • 14
    • 6
    • 4
    • 1
    Western Blotting (WB), ELISA
    Spezifität
    Human CDKN2B / p15 INK4b. This antibody is expected to recognize isoform 2 (NP_511042.1) only.
    Aufreinigung
    Immunoaffinity purified
    Immunogen
    Synthetic peptide C-RQGARERGARP from the C-terminus of human CDKN2B / p15 INK4b (NP_004927.2, NP_511042.1). Percent identity by BLAST analysis: Human, Marmoset (100%).

    Type of Immunogen: Synthetic peptide
    Top Product
    Discover our top product CDKN2B Primärantikörper
  • Applikationshinweise
    Approved: Peptide-ELISA (1:128000), WB (1 - 3 μg/mL)

    Usage: Peptide ELISA: antibody detection limit dilution 1:128000. Western blot: Approx 12+14kD bands observed in Human Gastrointestinal cancer lysates (calculated MW of 8.1kD according to NP_511042.1). The observed 14kD cannot represent isoform 1 and therefore it most likely represents another post translational modification of isoform 2. Recommended concentration: 1-3 μg/mL.
    Kommentare

    Target Species of Antibody: Human

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    Tris-buffered saline,  pH 7.3, 0.5 % BSA, 0.02 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Avoid freeze-thaw cycles.
  • Target
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Andere Bezeichnung
    CDKN2B / p15 INK4b (CDKN2B Produkte)
    Synonyme
    p14-INK4b antikoerper, cdk4l antikoerper, ink4b antikoerper, mts2 antikoerper, p15 antikoerper, p15ink4b antikoerper, tp15 antikoerper, CDK4I antikoerper, INK4B antikoerper, MTS2 antikoerper, P15 antikoerper, TP15 antikoerper, p15INK4b antikoerper, AV083695 antikoerper, INK4b antikoerper, p15(INK4b) antikoerper, CDKN2A antikoerper, cyclin dependent kinase inhibitor 2B antikoerper, Cyclin-dependent kinase 4 inhibitor B antikoerper, cyclin-dependent kinase inhibitor 2B antikoerper, cyclin-dependent kinase inhibitor 2B L homeolog antikoerper, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) antikoerper, CDKN2B antikoerper, cdn2b antikoerper, cdkn2b antikoerper, cdkn2b.L antikoerper, Cdkn2b antikoerper
    Hintergrund
    Name/Gene ID: CDKN2B

    Synonyms: CDKN2B, CDK inhibitory protein, CDK4B inhibitor, INK4B, MTS2, Multiple tumor suppressor 2, p14_INK4B, p15, p14_CDK inhibitor, p15 CDK inhibitor, p15 INK4b, p15-INK4b, p15_INK4B, p14-INK4b, p15INK4b, CDK4I, MTS-2, TP15
    Gen-ID
    1030
    NCBI Accession
    NP_004927, NP_511042
    UniProt
    P42772
    Pathways
    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Kundenservice